We use our own and third party cookies to offer you our services, customize and analyze your browsing and show you advertising related to your preferences. By continuing to browse, we consider that you accept its use. You can change the settings and get more information in the
The strategic goal of the research activity led by the Maternal and Fetal Medicine Service is to seek solutions for diseases of prenatal origin by identifying the mechanisms involved in fetal, cerebral and cardiac reprogramming. It also focuses on consolidating existing lines of work in different areas such as perinatal infections, HIV and neonatal infection, fetal therapy and surgery, screening strategies and prediction of fetal and maternal diseases in large populations, preeclampsia and prematurity.
The research is carried out at the August Pi Sunyer Institute for Biomedical Research (IDIBAPS), in the area of Liver, Digestive System and Metabolism in the following group:
It also carries out its research at the CIBER of Rare Diseases.
The Maternal and Fetal Medicine Service is the world's second largest production center for perinatal medicine research. Since 2010, it has published more than 350 studies in indexed journals, has 22 competitively funded projects underway and the research group has an annual budget of 1.8 million euros.
The defined lines of research are:
Fetal cardiovascular programming
Fetal therapy and surgery
Atmosphere and complications of pregnancy
There are fellowship programs in maternal and fetal medicine research and quality in fetal medicine (2 years in duration)
Discover the projects and active clinical trials of this service.